gonorrhea

The GenFlex is a sample-to-result molecular diagnostic platform that includes sample collection, processing, amplification, and detection, the company said.

The Ithaca, New York-based firm has submitted its molecular diagnostic instrument along with a test to detect chlamydia, gonorrhea, and trichomonas.

FIND also announced support for projects from Axxin and DNC Dx for point-of-care detection of sexually transmitted infections.  

The company said that the decline in revenues reflected lower industry-wide reimbursement rates under PAMA.

MyCartis said that the new company, Antelope Dx, is developing a home test to diagnose Chlamydia trachomatis and Neisseria gonorrhea.